tetano
Editor, Senior Moderator
Clin Chem Lab Med
. 2023 Nov 27.
doi: 10.1515/cclm-2023-0846. Online ahead of print. SARS-CoV-2 subgenomic RNA: formation process and rapid molecular diagnostic methods
Xiao Ge[SUP] 1 [/SUP], Huizi Zhou[SUP] 1 [/SUP], Fangyuan Shen[SUP] 1 [/SUP], Guimao Yang[SUP] 2 [/SUP], Yubo Zhang[SUP] 1 [/SUP], Xiaoyu Zhang[SUP] 1 [/SUP], Heng Li[SUP] 1 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused coronavirus disease-2019 (COVID-19) is spreading worldwide and posing enormous losses to human health and socio-economic. Due to the limitations of medical and health conditions, it is still a huge challenge to develop appropriate discharge standards for patients with COVID-19 and to use medical resources in a timely and effective manner. Similar to other coronaviruses, SARS-CoV-2 has a very complex discontinuous transcription process to generate subgenomic RNA (sgRNA). Some studies support that sgRNA of SARS-CoV-2 can only exist when the virus is active and is an indicator of virus replication. The results of sgRNA detection in patients can be used to evaluate the condition of hospitalized patients, which is expected to save medical resources, especially personal protective equipment. There have been numerous investigations using different methods, especially molecular methods to detect sgRNA. Here, we introduce the process of SARS-CoV-2 sgRNA formation and the commonly used molecular diagnostic methods to bring a new idea for clinical detection in the future.
Keywords: COVID-19; detection; molecular diagnostic techniques; subgenomic RNA.
. 2023 Nov 27.
doi: 10.1515/cclm-2023-0846. Online ahead of print. SARS-CoV-2 subgenomic RNA: formation process and rapid molecular diagnostic methods
Xiao Ge[SUP] 1 [/SUP], Huizi Zhou[SUP] 1 [/SUP], Fangyuan Shen[SUP] 1 [/SUP], Guimao Yang[SUP] 2 [/SUP], Yubo Zhang[SUP] 1 [/SUP], Xiaoyu Zhang[SUP] 1 [/SUP], Heng Li[SUP] 1 [/SUP]
Affiliations
- PMID: 38000044
- DOI: 10.1515/cclm-2023-0846
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused coronavirus disease-2019 (COVID-19) is spreading worldwide and posing enormous losses to human health and socio-economic. Due to the limitations of medical and health conditions, it is still a huge challenge to develop appropriate discharge standards for patients with COVID-19 and to use medical resources in a timely and effective manner. Similar to other coronaviruses, SARS-CoV-2 has a very complex discontinuous transcription process to generate subgenomic RNA (sgRNA). Some studies support that sgRNA of SARS-CoV-2 can only exist when the virus is active and is an indicator of virus replication. The results of sgRNA detection in patients can be used to evaluate the condition of hospitalized patients, which is expected to save medical resources, especially personal protective equipment. There have been numerous investigations using different methods, especially molecular methods to detect sgRNA. Here, we introduce the process of SARS-CoV-2 sgRNA formation and the commonly used molecular diagnostic methods to bring a new idea for clinical detection in the future.
Keywords: COVID-19; detection; molecular diagnostic techniques; subgenomic RNA.